Zylox-Tonbridge Medical Technology Co., Ltd. 13D and 13G filings for Avinger, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-03 06:26 am Purchase |
2024-03-05 | 13D | Avinger, Inc. AVGR |
Zylox-Tonbridge Medical Technology Co., Ltd. | 1,981,655 49.900% |
1,559,439 (+369.35%) |
Filing |
| 2024-03-14 9:37 pm Purchase |
2024-03-05 | 13D | Avinger, Inc. AVGR |
Zylox-Tonbridge Medical Technology Co., Ltd. | 422,216 19.900% |
422,216 (New Position) |
Filing |